Tamer E. Fandy

1.8k citations
37 papers · 1.2k · h-index 18

Impact in

  • Hematology top 5%
    • Acute Myeloid Leukemia Research
    • Epigenetics and DNA Methylation
    • Histone Deacetylase Inhibitors Research
    • Protein Degradation and Inhibitors
    • Cell death mechanisms and regulation
    • RNA modifications and cancer
    • Cancer-related gene regulation

Papers in

    • Epigenetics and DNA Methylation 13
    • Histone Deacetylase Inhibitors Research 12
    • Cancer-related gene regulation 6
    • RNA modifications and cancer 4
    • RNA Interference and Gene Delivery 3
    • Acute Myeloid Leukemia Research 8

Tamer E. Fandy

34 papers receiving 1.2k citations

Peers

Tamer E. Fandy
Comparison fields: 5 of 102
  • Hematology 318
  • Molecular Biology 874
  • Oncology 213
  • Molecular Medicine 38
  • Genetics 73
Replace Abhisek Swaika with:
Abhisek Swaika United States
Karin von Schwarzenberg Germany
Darrell Nix United States
Francesca Buontempo Italy
Elizabeth Hopper-Borge United States
Łukasz Sędek Poland
Peng Zou China
Elaine Willmore United Kingdom
Fankai Meng China
Cheng Ean Chee Singapore
Tamer E. Fandy relative to Abhisek Swaika United States Abhisek Swaika's profile →
Citations per field
00.5×
Abhisek Swaika · 1×
Citations per year

Countries citing papers authored by Tamer E. Fandy

Since Specialization
Citations

This map shows the geographic impact of Tamer E. Fandy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tamer E. Fandy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tamer E. Fandy more than expected).

Fields of papers citing papers by Tamer E. Fandy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tamer E. Fandy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tamer E. Fandy. The network helps show where Tamer E. Fandy may publish in the future.

Co-authors

The 25 scholars most cited alongside Tamer E. Fandy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Tamer E. Fandy Line = papers co-authored together Tamer E. Fandy links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2009231
2 2005130
3 201475
4 200873
5 200571
6 201767
7 200664
8 200963
9 200858
10 200451
11 201435
12 202032
13 202130
14 200630
15 200626
16 201524
17 200723
18 201517
19 202016
20 200115

About Tamer E. Fandy

Tamer E. Fandy is a scholar working on Molecular Biology, Hematology, Oncology, Epidemiology and Pharmacology, having authored 37 papers that have together received 1.2k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (13 papers), Histone Deacetylase Inhibitors Research (12 papers), Acute Myeloid Leukemia Research (8 papers), Cancer-related gene regulation (6 papers), RNA modifications and cancer (4 papers), Pharmacogenetics and Drug Metabolism (3 papers), Cancer-related Molecular Pathways (3 papers) and RNA Interference and Gene Delivery (3 papers). The work is most often cited by research in Hematology (318 citations), Molecular Biology (874 citations), Oncology (213 citations), Molecular Medicine (38 citations) and Genetics (73 citations). Tamer E. Fandy has collaborated with scholars based in United States, Egypt and Poland. Frequent co-authors include Rohit Srivastava, Sharmila Shankar, Steven D. Gore, Anchalee Jiemjit, Douglas D. Ross, Hetty E. Carraway, Edward A. Sausville, Hazem E. Hassan, Jonathan D. Licht and María E. Figueroa. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, Blood, Scientific Reports, Clinical Cancer Research and Neoplasia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact